#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13684	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2636	641.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1715	1715	C	841	C,T,G	837,2,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3950	730.9	0	.	n	.	0	T695C	SNP	695	695	T	1205	1205	C	872	C,T,G	870,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3950	730.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1847	1847	A	967	A,C	964,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3950	730.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2481	2481	C	828	C	828	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3950	730.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2555	2555	A	795	A	795	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3950	730.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3107	3107	C	786	C,A	784,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1858	folP	855	855	100.0	folP.l15.c4.ctg.1	2080	111.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1284	1286	AGC	172;172;172	A,G,C;G;C	170,1,1;171;171	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4514	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3859	145.9	1	SNP	p	S91F	1	.	.	271	273	TTC	832	834	TTC	174;173;173	T,G;T,A;C	172,2;172,1;173	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4514	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3859	145.9	1	SNP	p	D95G	1	.	.	283	285	GGC	844	846	GGC	180;179;180	G;G;C,A	180;179;179,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4514	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3859	145.9	1	SNP	p	G95N	0	.	.	283	285	GGC	844	846	GGC	180;179;180	G;G;C,A	180;179;179,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1812	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1923	117.5	1	SNP	p	G45D	0	.	.	133	135	GGC	835	837	GGC	209;211;208	G,T;G;C	208,1;211;208	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1046	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1601	81.5	0	.	n	.	0	A197.	DEL	197	197	A	926	926	A	230	A	230	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3515	157.7	1	SNP	p	D86N	0	.	.	256	258	GAC	917	919	GAC	204;206;205	G;A,C;C	204;205,1;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3515	157.7	1	SNP	p	R87W	0	.	.	259	261	CGT	920	922	CGT	204;204;206	C,A;G;T,A	203,1;204;205,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3515	157.7	1	SNP	p	S87R	1	.	.	259	261	CGT	920	922	CGT	204;204;206	C,A;G;T,A	203,1;204;205,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3515	157.7	1	SNP	p	R87I	0	.	.	259	261	CGT	920	922	CGT	204;204;206	C,A;G;T,A	203,1;204;205,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3515	157.7	1	SNP	p	S88P	0	.	.	262	264	TCC	923	925	TCC	205;210;213	T,G;C;C,G	204,1;210;212,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3892	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3132	155.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1794	1796	GGC	192;192;190	G;G;C,G	192;192;189,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1426	1428	GCA	210;212;212	G,C;C;A	209,1;212;212	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1429	1431	ATC	210;210;211	A,C;T,G;C,G,T	209,1;208,2;209,1,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1441	1443	GTG	226;225;225	G,A;T;G	225,1;225;224	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1441	1443	GTG	226;225;225	G,A;T;G	225,1;225;224	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1945	1947	ACC	187;187;186	A;C;C,G,T	187;187;184,1,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1999	2001	GCG	205;205;200	G;C;G	205;205;200	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1999	2001	GCG	205;205;200	G;C;G	205;205;200	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2122	2124	AGC	199;198;198	A;G;C	199;198;198	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2131	2133	GGC	200;201;198	G;G,A;C	200;200,1;198	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3574	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2765	161.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2149	2151	CCG	196;199;194	C,A;C;G	195,1;199;194	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5056	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3648	172.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1862	1864	CCG	221;220;216	C,G,A;C;G,A	219,1,1;220;215,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2122	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2333	113.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	853	853	C	149	C,A	148,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	25;27;28	T;T;A	25;27;28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	50;50;50	C;A;T	50;50;50	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	50;50;50	A;G;T	50;50;50	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	50;50;50	T;A;C	50;50;50	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	R307A	NONSYN	919	921	AGA	160	162	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	172	174	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	175	177	GAC	3;3;3	G;A;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	181	183	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	187	189	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	193	195	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	196	198	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	199	201	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	222	90.54	porB1a.l15.c4.ctg.3	608	16.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	205	207	GTT	5;5;5	G;T,G;T	5;4,1;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	100	94.0	porB1a.l15.c4.ctg.4	182	47.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	54;53;49	A;C;G	54;53;49	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	100	94.0	porB1a.l15.c4.ctg.4	182	47.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	18;16;16	C;A;A	18;16;16	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	659	661	GAA	255;255;252	G,T;A;A,C	254,1;255;251,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	947	949	GAT	247;250;250	G;A,C;T	246;249,1;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1070	1072	TCA	245;247;249	T,C;C;A	244,1;247;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1199	1201	GTC	272;269;270	G,C;T,G;C	271,1;268,1;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1529	1531	GCA	215;218;220	G,C;C;A	214,1;217;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	1	SNP	p	G120K	1	.	.	358	360	AAG	905	907	AAG	242;243;243	A;A;G	242;243;243	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	1	SNP	p	A121D	1	.	.	361	363	GAC	908	910	GAC	245;248;250	G;A,G;C,T	245;247,1;249,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1948	176.9	1	SNP	p	D121N	0	.	.	361	363	GAC	908	910	GAC	245;248;250	G;A,G;C,T	245;247,1;249,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9216	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5333	215.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1620	104.5	1	SNP	p	V57M	1	.	.	169	171	ATG	821	823	ATG	246;245;244	A;T;G,C	246;245;243,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
